SCHEMBL4957433

SCHEMBL4957433

[CH2]C(N)CCCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3862134 0.91
SCHEMBL1509652 0.80
SCHEMBL1131574 0.73 ENPEP (0.36)
SCHEMBL484146 0.73
SCHEMBL23467011 0.73 ALDH1A1 (0.32)
SCHEMBL5400057 0.71
SCHEMBL471954 0.71
SCHEMBL17993940 0.71
SCHEMBL284090 0.71
SCHEMBL726672 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103228629-A Substituted cyclopentyl -azines as CaSR- active compounds LEO PHARMA AS 2013-07-31 CN claimed
US-20160374945-A1 PHARMACEUTICAL COMPOSITIONS OF DISPERSIONS OF DRUG AND NEUTRAL POLYMERS BEND RESEARCH, INC. (US) 2016-12-29 US disclosed
US-9468604-B2 Pharmaceutical compositions of dispersions of drug and neutral polymers BEND RESEARCH, INC. (US) 2016-10-18 US disclosed
US-20140210117-A1 PHARMACEUTICAL COMPOSITIONS OF DISPERSIONS OF DRUG AND NEUTRAL POLYMERS BEND RESEARCH, INC. (US) 2014-07-31 US disclosed
US-20130267516-A1 SUBSTITUTED CYCLOPENTYL-AZINES AS CASR-ACTIVE COMPOUNDS LEO PHARMA A/S (DK) 2013-10-10 US disclosed
EP-2643298-A1 SUBSTITUTED CYCLOPENTYL - AZINES AS CASR- ACTIVE COMPOUNDS Leo Pharma A/S (DK) 2013-10-02 EP disclosed
CN-103228629-A Substituted cyclopentyl -azines as CaSR- active compounds LEO PHARMA AS 2013-07-31 CN disclosed
WO-2012069402-A1 SUBSTITUTED CYCLOPENTYL - AZINES AS CASR- ACTIVE COMPOUNDS LEO PHARMA A/S (DK) 2012-05-31 WO disclosed
CN-101501092-B Catalyst composition for polyurethane resin production and method for producing polyurethane resin TOSOH CORP 2011-09-28 CN disclosed
CN-101501092-A Catalyst composition for polyurethane resin production and method for producing polyurethane resin TOSOH CORP (JP) 2009-08-05 CN disclosed
CN-1131216-C Condensed 1, 2-indanes and their pharmaceutically acceptable salts, process for their preparation and their use TAIHO PHARMACEUTICAL CO LTD (JP) 2003-12-17 CN disclosed
EP-1358181-A1 SUBSTITUTED PYRROLIDINES AS CCR-3 RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2003-11-05 EP disclosed
US-20030199532-A1 2,4-substituted pyrrolidine derivatives-CCR-3 receptor antagonists KERTESZ DENIS JOHN (US) 2003-10-23 US disclosed
US-20030091643-A1 Amorphous mixture of acid sensitive drug and addition polymer; chemical resistance, stability BEND RESEARCH, INC. 2003-05-15 US disclosed
US-6552028-B2 Inhibiting the binding of eotaxin to chemokine-3 (ccr-3) receptor; antiasthmatics SYNTEX (U.S.A.) LLC 2003-04-22 US disclosed
WO-2003000235-A1 PHARMACEUTICAL COMPOSITIONS OF DISPERSIONS OF DRUGS AND NEUTRAL POLYMERS PFIZER PRODUCTS INC. (US) 2003-01-03 WO disclosed
US-20020198255-A1 2,4-substituted pyrrolidine derivatives-CCR-3 receptor antagonists SYNTEX (U.S.A.) LLC 2002-12-26 US disclosed
WO-2002050064-A1 SUBSTITUTED PYRROLIDINES AS CCR-3 RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-06-27 WO disclosed
CN-1272873-A Laundry detergent compositions with amino acid based polymers to provide appearance and integrity benefits to fabrics laundered therewith PROCTER & GAMBLE (US) 2000-11-08 CN disclosed
CN-1130903-A Condensed 1,2-indene dihydride and its salt for medicine TAIHO PHARMACEUTICAL CO LTD (JP) 1996-09-11 CN disclosed